SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: AMENDMENT TO LOANOUTREEMENT THIS AMENDMENT TO LOANOUTREEMENT (Amendment)

[AMENDMENT TO LOANOUTREEMENT THIS AMENDMENT TO LOANOUTREEMENT (Amendment) is made and entered into of May 26, 2009, by and betweenystar Bio-Pharmaceuticalmpany, a Nevadarporation (thempany), and Worldwide Officers, aliforniarporation (the Lender).pitalized terms used herein and undefined shall have the meanings set forth in that certain Loanoutreement (defined in the Recitals below).] [SKYSTAR BIO-PHARMACEUTICALMPANY Room 10601, Jiezuo Plaza No. 4, Fenghui Road South Gaoxin District, Xian Province Peoples Republic of China May 26, 2009 Mr. Mark D. Chen Suite 10-64 #9 Jianguomenwai Avenue Beijing, P.R. China 100600 Re: Director Offer Letter Dear Mr. Chen:ystar Bio-Pharmaceuticalmpany, a Nevadarporation (thempany), is pleased to offer you a director position on]

By | 2016-02-05T05:48:31+00:00 May 27th, 2009|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

LONG [eLong,] 6-K: (Original Filing)

[eLong, Reports First Quarter 2009 Unaudited Financial Results BEIJING, China May27, 2009 eLong, (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for the first quarter ended March31, 2009. Highlights Total gross revenues net revenues Travel revenues before business tax and surcharges (figures in RMB 000s; some numbers may]

By | 2016-02-07T02:43:45+00:00 May 27th, 2009|Categories: Chinese Stocks, LONG, SEC Original|Tags: , , , , , |0 Comments
Read More

LONG [eLong,] 6-K: eLong, Reports First Quarter 2009 Unaudited Financial Results

[eLong, Reports First Quarter 2009 Unaudited Financial Results BEIJING, China May27, 2009 eLong, (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for the first quarter ended March31, 2009. Highlights Total gross revenues net revenues Travel revenues before business tax and surcharges (figures in RMB 000s; some numbers may]

By | 2016-02-07T02:45:20+00:00 May 27th, 2009|Categories: Chinese Stocks, LONG, Webplus ver|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 Investments in Infrastructure Expected To Positively Effect Performance This Year New York, New York – May 27, 2009 – Biostar Pharmaceuticals, Inc. (“Biostar” or the “Company”) (OTCBB: BSPM) today reported financial results for the three months ended March 31, 2009. The Company reported revenue of $7,447,664]

By | 2016-03-03T16:19:38+00:00 May 27th, 2009|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings

[Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 Investments in Infrastructure Expected To Positively Effect Performance This Year New York, New York – May 27, 2009 – Biostar Pharmaceuticals, Inc. (“Biostar” or the “Company”) (OTCBB: BSPM) today reported financial results for the three months ended March 31, 2009. The Company reported revenue of $7,447,664]

By | 2016-03-03T16:21:19+00:00 May 27th, 2009|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar